Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

Thorax. Published Online First: 1 February 2008. doi:10.1136/thx.2007.081752
Copyright © 2008 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text (Rapid PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Oliver, B. G
Right arrow Articles by Johnston, S. L
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oliver, B. G
Right arrow Articles by Johnston, S. L

Papers

Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages

Brian G Oliver 1*, Sam Lim 2, Peter Wark 3, Vasile Laza-Stanca 4, Nicholas J.C. King 5, Judith L Black 6, Janette K Burgess 6, Michael Roth 7 and Sebastian L Johnston 8

1 The Univeristy of Sydney, Australia
2 ANZAC research institute, Univeristy of Sydney, Australia
3 Respiratory Medicine HMRI, Australia
4 Department of Respiratory Medicine, Imperial College, United Kingdom
5 The University of Sydney, Australia
6 University of Sydney Department of Pharmacology, Australia
7 The Woolcock Institute for Medical Research, Australia
8 Department of Respiratory Medicine, National Heart and Lung Institute, Imperial College London,, United Kingdom

* To whom correspondence should be addressed. E-mail: boliver{at}med.usyd.edu.au.

Accepted 12 December 2007


*   Abstract

Rhinovirus infection is responsible for considerable morbidity and mortality as the major cause of exacerbations of asthma, and is also known to induce exacerbations of cystic fibrosis and chronic obstructive pulmonary disease. Exacerbations of these diseases are also frequently associated with bacterial and atypical bacterial infection. Alveolar macrophages are the major immune cells in the airways and are important in defence against bacterial infections. Therefore we investigated whether rhinovirus modifies cytokine release, the pattern recognition receptor (PRR) expression and phagocytosis by human alveolar macrophages in response to bacterial products. Viable rhinovirus was detected in macrophages up to 3 days after exposure and viral RNA expression persisted to 10 days. Infectious but not UV-inactivated rhinovirus increased TNF-{alpha} and IL-8 release by macrophages. In contrast, infectious rhinovirus impaired lipopolysaccharide and lipoteichoic acid induced TNF-{alpha} and IL-8 secretion by macrophages. Rhinovirus-induced impairment of macrophage antibacterial immune responses did not involve IL-10, PGE2, or down-regulation of TLR2. Furthermore the macrophage phagocytic response to labelled bacterial particles, but not to latex beads, was impaired. In conclusion, we have identified impairment of cytokine responses to bacterial lipopolysaccharide and lipoteichoic acid by alveolar macrophages in response to infectious rhinovirus. Virus induced impairment of antibacterial host defence has important implications in the pathogenesis of exacerbations of respiratory diseases.


Keywords: COPD, Rhinovirus, asthma, bacteria, superinfection







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & British Thoracic Society